| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species.
|
J Clin Microbiol
|
2004
|
4.70
|
|
2
|
Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program.
|
J Clin Microbiol
|
2004
|
4.51
|
|
3
|
Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.
|
J Clin Microbiol
|
2005
|
3.41
|
|
4
|
Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of candida species.
|
Antimicrob Agents Chemother
|
2002
|
2.26
|
|
5
|
Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates.
|
Antimicrob Agents Chemother
|
2002
|
2.20
|
|
6
|
In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003.
|
J Antimicrob Chemother
|
2004
|
1.88
|
|
7
|
Assessment of ribosomal large-subunit D1-D2, internal transcribed spacer 1, and internal transcribed spacer 2 regions as targets for molecular identification of medically important Aspergillus species.
|
J Clin Microbiol
|
2005
|
1.86
|
|
8
|
An epidemic of coccidioidomycosis in Arizona associated with climatic changes, 1998-2001.
|
J Infect Dis
|
2005
|
1.60
|
|
9
|
Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole.
|
Antimicrob Agents Chemother
|
2005
|
1.52
|
|
10
|
Candida parapsilosis characterization in an outbreak setting.
|
Emerg Infect Dis
|
2004
|
1.51
|
|
11
|
Histoplasmosis associated with exploring a bat-inhabited cave in Costa Rica, 1998-1999.
|
Am J Trop Med Hyg
|
2004
|
1.47
|
|
12
|
Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome.
|
Antimicrob Agents Chemother
|
2006
|
1.37
|
|
13
|
Resolution of discrepant results for Candida species identification by using DNA probes.
|
J Clin Microbiol
|
2004
|
1.21
|
|
14
|
Drug resistance genes and trailing growth in Candida albicans isolates.
|
J Antimicrob Chemother
|
2003
|
1.10
|
|
15
|
Stability of allelic frequencies and distributions of Candida albicans microsatellite loci from U.S. population-based surveillance isolates.
|
J Clin Microbiol
|
2003
|
1.09
|
|
16
|
Fungal infections among returning travelers.
|
Clin Infect Dis
|
2002
|
1.03
|
|
17
|
Candidemia in neonatal intensive care units: Barcelona, Spain.
|
Pediatr Infect Dis J
|
2006
|
0.99
|
|
18
|
Coccidioidomycosis among workers at an archeological site, northeastern Utah.
|
Emerg Infect Dis
|
2004
|
0.92
|
|
19
|
A large outbreak of histoplasmosis among American travelers associated with a hotel in Acapulco, Mexico, spring 2001.
|
Am J Trop Med Hyg
|
2003
|
0.91
|
|
20
|
Comparison of multilocus sequence typing and Ca3 fingerprinting for molecular subtyping epidemiologically-related clinical isolates of Candida albicans.
|
Med Mycol
|
2006
|
0.87
|
|
21
|
Outbreak of invasive aspergillosis among renal transplant recipients.
|
Transplantation
|
2003
|
0.87
|
|
22
|
Persistence of oropharyngeal Candida albicans strains with reduced susceptibilities to fluconazole among human immunodeficiency virus-seropositive children and adults in a long-term care facility.
|
J Clin Microbiol
|
2003
|
0.85
|
|
23
|
A large histoplasmosis outbreak among high school students in Indiana, 2001.
|
Pediatr Infect Dis J
|
2004
|
0.82
|
|
24
|
Rapid quantification of drug resistance gene expression in Candida albicans by reverse transcriptase LightCycler PCR and fluorescent probe hybridization.
|
J Clin Microbiol
|
2004
|
0.81
|
|
25
|
Evolving strategies in the management of aspergillosis.
|
Expert Opin Pharmacother
|
2008
|
0.81
|